{"data":[{"accessionNo":"0000919574-26-004959","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":3428571,"percentOfClass":4,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000919574-26-004959","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":3428571,"percentOfClass":4,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000919574-26-004959","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":3428571,"percentOfClass":4,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001346824-26-000216","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-07-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":10666523,"percentOfClass":9.9,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001346824-26-000216","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-07-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":10666523,"percentOfClass":9.9,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001346824-26-000216","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-07-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":10666523,"percentOfClass":9.9,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001346824-26-000216","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-07-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10666523,"percentOfClass":9.9,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000315066-26-002045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS INC","ticker":"INO","cusip":"45773H409","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":8454797,"percentOfClass":10.3,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000315066-26-002045","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS INC","ticker":"INO","cusip":"45773H409","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":8454797,"percentOfClass":10.3,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0002100119-26-001406","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals Inc","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":4161566,"percentOfClass":5.05,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000919574-26-003181","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"HIGHBRIDGE CAPITAL MANAGEMENT LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":6190475,"percentOfClass":8.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000919574-26-002915","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":4233529,"percentOfClass":5.84,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000919574-26-002915","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":4233529,"percentOfClass":5.84,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000919574-26-002915","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":"45773H409","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":4233529,"percentOfClass":5.84,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000315066-26-001216","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS INC","ticker":"INO","cusip":"45773H409","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9339614,"percentOfClass":13.5,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000315066-26-001216","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS INC","ticker":"INO","cusip":"45773H409","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9339614,"percentOfClass":13.5,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-26-001178","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":4000000,"percentOfClass":5.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-26-001178","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":4000000,"percentOfClass":5.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-26-001178","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":4000000,"percentOfClass":5.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000102909-26-000224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals Inc","ticker":"INO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":3315579,"percentOfClass":4.96,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001274173-25-000337","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-11-28","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":6666295,"percentOfClass":9.99,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000315066-25-002964","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS INC","ticker":"INO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-11-28","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9846664,"percentOfClass":14.8,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000315066-25-002964","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS INC","ticker":"INO","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-11-28","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9846664,"percentOfClass":14.8,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-25-005183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS","ticker":"INO","cusip":null,"securityClass":"Class A Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":4000000,"percentOfClass":7.53,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-25-005183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS","ticker":"INO","cusip":null,"securityClass":"Class A Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":4000000,"percentOfClass":7.53,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-25-005183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS","ticker":"INO","cusip":null,"securityClass":"Class A Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":4000000,"percentOfClass":7.53,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001274173-25-000276","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARAMACEUITICALS, INC.","ticker":"INO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":3266260,"percentOfClass":6.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001274173-25-000276","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"INOVIO PHARAMACEUITICALS, INC.","ticker":"INO","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Janus Henderson Biotech Innovation Master Fund Ltd","reportingCik":null,"personType":"IV","sharesOwned":2802530,"percentOfClass":5.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-25-004827","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":1314796,"percentOfClass":2.41,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-25-004827","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1314796,"percentOfClass":2.41,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0001172661-25-004827","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001055726","issuerName":"INOVIO PHARMACEUTICALS, INC.","ticker":"INO","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":1314796,"percentOfClass":2.41,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000902664-25-004899","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":5517650,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000902664-25-004899","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":5517650,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/ino"},{"accessionNo":"0000902664-25-004899","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001055726","issuerName":"Inovio Pharmaceuticals, Inc.","ticker":"INO","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":5517650,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/ino"}],"updatedAt":"2026-11-03T23:28:31.806Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ino","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}